What are the unique human capital demands faced by Life Science companies with medical device and pharmaceutical entities? With the recent boom in the drug-coated stent market, now more than ever these companies must foster the talent necessary to keep pace with the lucrative potential of drug-device combination products. This whitepaper paper provides valuable insight into the pharma and medical device sectors and the universal leadership challenge of integrating diversified businesses.

Sign Up for our 'This Week in Leadership' email